Opaleye Management Inc. recently boosted its investment in Eton Pharmaceuticals Inc. by acquiring 385,000 shares, reflecting a significant endorsement of Eton's market potential. Opaleye focuses on healthcare opportunities and holds a diverse portfolio valued at around $430 million.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing